Teriparatide has the disadvantage of needing
to be administered by injection daily, something that many people
are not comfortable doing. It is also very expensive, costing
about $516 per month versus $65 for alendronate.
The recommended dose is 20 micrograms daily, given into the thigh
or abdomen. It comes in a preloaded pen with 28 doses. A doctor,
nurse, or pharmacist should explain how to use it. It should be
kept in the refrigerator. A new needle must be used for each injection,
and the remaining medicine returned to the refrigerator. The pharmacist
should also explain a way to safely dispose of needles.
The reason the drug must be taken every day is because the body
eliminates it so quickly. The concentration in the bloodstream
peaks about 30 minutes after injection. The half-life is abour
one hour when administered by subcutaneous injection. Within three
hours, the drug is down to such low levels that it is essentially
gone. The body clears the drug as it normally clears external
materials.
Duration of treatment is 18-24 months. Doctors evaluate progress
during this period and may recommend continuing treatment. Teriparatide
should not be combined with bisphosphonates.
The goals of osteoporosis treatment are generally to stop or
slow bone density decline, to prevent fractures, and to control
pain from the disease.
A 2006 study
in the Journal of Drug Assessment concluded that although
teriparatide is the most expensive therapy for preventing bone
fractures in osteoporosis patients, it is on the "cost-effectiveness
frontier" - meaning it is a good choice for some patients.
Surgeon
General on Prevention and Treatment of Bone Diseases.
Recommendations released by the American College of Physicians
in September 2008 included
the statement that doctors should offer drugs to people with
osteoporosis, and that doctors should consider preventative treatment
for osteoporosis. The organization said teriparatide prevented
spine fractures, but noted that evidence for other types of fractures
is mixed. |